[1] Chu CY, Su HM, Hsu PC, et al. Impact of chronic kidney disease in early invasive versus early conservative revascularization strategies in non-ST-segment elevation acute coronary syndromes: a population-based study from NHIRD of Taiwan. Nephron Clin Pract. 2013;124(1-2):38-46. [2] Toth PP. Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract. 2008;62(8): 1246-1254. [3] Kindermann W. Cardiovascular side effects of anabolic-androgenic steroids. Herz. 2006;31(6):566-573. [4] Clark LT. Issues in minority health: atherosclerosis and coronary heart disease in African Americans. Med Clin North Am. 2005;89(5):977-1001. [5] Health Quality Ontario. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(13):1-60. [6] Urbano-Moral JA, Patel AR, Maron MS, et al. Three-dimensional speckle-tracking echocardiography: methodological aspects and clinical potential. Echocardiography. 2012;29(8):997-1010.[7] Xie MY, Lv Q, Wang J, et al. Assessment of myocardial segmental function with coronary artery stenosis in multi-vessel coronary disease patients with normal wall motion. Eur Rev Med Pharmacol Sci. 2016;20(8): 1582-1589.[8] Enomoto M, Ishizu T, Seo Y, et al. Myocardial dysfunction identified by three-dimensional speckle tracking echocardiography in type 2 diabetes patients relates to complications of microangiopathy. J Cardiol. 2016;68(4): 282-287. [9] Lipiec P, Wejner-Mik P, Wdowiak-Okrojek K, et al. Fusion of morphological data obtained by coronary computed tomography angiography with quantitative echocardiographic data on regional myocardial function. Cardiol J. 2016;23(3): 264-269. [10] Narimani S, Hosseinsabet A, Pourhosseini H. Effect of Coronary Slow Flow on the Longitudinal Left Ventricular Function Assessed by 2-Dimensional Speckle-Tracking Echocardiography. J Ultrasound Med. 2016;35(4):723-729. [11] Ba?aran Ö, Tigen K, Gözübüyük G, et al. Predictive role of left atrial and ventricular mechanical function in postoperative atrial fibrillation: a two-dimensional speckle-tracking echocardiography study. Turk Kardiyol Dern Ars. 2016;44(1): 45-52. [12] 张恒,罗显荣,刘光杰,等.超声二维应变成像对正常人左室壁纵向收缩功能的定量研究[J].实用医学杂志, 2012,28(24): 4093-4096.[13] Jasaityte R, Heyde B, D’Hooge J. Current state of three-dimensional myocardial strain estimation using echocardiography. J Am Soc Echocardiogr. 2013;26(1):15-28.[14] 张瑞芳,翁育娟,宋毅,等.三维斑点追踪技术评价正常人左房心肌应变的初步研究[J].中华超声影像学杂志,2013,22(7):572-575.[15] 柏刚,勾常龙,张忠磊,等.三维纵向应变成像对高危冠状动脉粥样硬化性心脏病的预测价值[J].临床超声医学杂志, 2016,18(11): 730-733.[16] Kleijn SA, Aly MF, Terwee CB, et al. Three-dimensional dimensional speckle tracking echocardiography for automatic assessment of global and regional left ventricular function based on area strain. J Am Soc Echocardiogr. 2011;24(3): 314-321.[17] Liu GB, Zhang GP, Ren QY, et al. Classification of ankle injury on radiography and magnetic resonance imaging: study protocol for a retrospective, self-controlled, clinical trial with 3-month followup. Clin Transl Orthop. 2016;1:170-176.[18] Chen Y, Qu S, Ma G, Meng JH, Ni XL. Femoral nerve block prevents deep venous thrombosis of the lower extremity after knee arthroplasty: a single-center randomized controlled trial. Clin Transl Orthop. 2016;1:1-5.[19] Stewart RAH, Held C, Hadziosmanovic N, et al. Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. J Am Coll Cardiol. 2017;70(14):1689-1700.[20] Krehbiel LM, Layne AS, Sandesara B, et al. Wearable technology to reduce sedentary behavior and CVD risk in older adults: design of a randomized controlled trial. Contemp Clin Trials Commun. 2017;6:122-126. [21] Vinereanu D, Al-Khalidi HR, Rao MP, et al. Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF). Am Heart J. 2017;192:38-47.[22] Albert MA, Durazo EM, Slopen N, et al. Cumulative psychological stress and cardiovascular disease risk in middle aged and older women: Rationale, design, and baseline characteristics. Am Heart J. 2017;192:1-12. [23] Weimar C, Bilbilis K, Rekowski J, et al. Safety of simultaneous coronary artery bypass grafting and carotid endarterectomy versus isolated coronary artery bypass grafting: a randomized clinical trial. Stroke. 2017;48(10):2769-2775. [24] Holman RR, Bethel MA, Mentz RJ, et al. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2017;377(13):1228-1239. [25] Ikonomidis I, Papadavid E, Makavos G, et al. Lowering Interleukin-12 Activity Improves Myocardial and Vascular Function Compared With Tumor Necrosis Factor-a Antagonism or Cyclosporine in Psoriasis. Circ Cardiovasc Imaging. 2017. doi: 10.1161/CIRCIMAGING.117.006283.[26] Vallejo-Vaz AJ, Robertson M, Catapano AL, et al. LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up. Circulation. 2017. doi: 10.1161/CIRCULATIONAHA.117.027966. [27] HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med. 2017; 377(13):1217-1227.[28] Kelly SA, Hartley L, Loveman E, et al. Whole grain cereals for the primary or secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017;8:CD005051. [29] McCarter RV, McKay GJ, Quinn NB, et al. Evaluation of coronary artery disease as a risk factor for reticular pseudodrusen. Br J Ophthalmol. 2017. doi: 10.1136/bjophthalmol-2017-310526. [30] Shroyer AL, Hattler B, Wagner TH, et al. Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass. N Engl J Med. 2017;377(7):623-632. [31] Musini VM, Gueyffier F, Puil L, et al. Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev. 2017;8:CD008276. [32] Lindholm D, Lindbäck J, Armstrong PW, et al. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. J Am Coll Cardiol. 2017;70(7):813-826. |